Riddhasree Bhattacharyya

Riddhasree Bhattacharyya

Auto-generated profile, based on publicly available information

Riddhasree Bhattacharyya

Machine Intelligence Unit, Indian Statistical Institute, Kolkata, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2026 in IEEE Transactions on Systems, Man, and Cybernetics: Systems
Verified
Journal Article
Closed access
RBRiddhasree Bhattacharyya
Riddhasree Bhattacharyya
SPSurochita Pal
Surochita Pal
SMSushmita Mitra
Sushmita Mitra

16 October 2025 in IEEE Access
Verified
Journal Article
Open access
RBRiddhasree Bhattacharyya
Riddhasree Bhattacharyya
SMSushmita Mitra
Sushmita Mitra
SBSugata Banerji
Sugata Banerji
Tumour cellularity (TC) is an important metric used in the cancer treatment journey, from monitoring the therapeutic response to guiding subsequent treatment decisions. It can be defined as the area occupied by malignant cells in a Region of Interest. Although deep learning (DL)-based automated systems have gained considerable momentum in medical image analysis, there are still challenges associated with efficient TC computation. The scope of performance improvement by comprehensively addressing issues of aleatoric uncertainty in TC labels and epistemic uncertainty in model parameters due to limited data remains unexplored. In this research, a novel regression-based framework is developed to address these two types of uncertainties for efficient computation of TC. While a loss function is introduced to handle aleatoric uncertainty, the epistemic uncertainty is handled by training the DL model in two stages by skilfully utilizing limited data. First, a novel task-specific pre-training is done in a semi-supervised framework to capture fine-grained cell-level features. Then, it is fine-tuned for effective TC computation. The experimental results show effective performance with different encoders, demonstrating robustness. Quantitative and qualitative results demonstrate the potential of the framework to serve as a robust tool for clinical decision support in cancer. Achieving a PK score of 0.95 and an R2 score of 0.88, it outperforms state-of-the-art histopathology-specific foundation models and other related methods w.r.t. both metrics and parameters. Thus, our framework offers a reliable and scalable solution for improved automated tumour cellularity estimation and for reducing the workload of pathologists.

2 December 2024
Verified
Book Chapter
Closed access
PDF file
SDShramana Dey
Shramana Dey
PDPallabi Dutta
Pallabi Dutta
RBRiddhasree Bhattacharyya
Riddhasree Bhattacharyya
SPSurochita Pal
Surochita Pal
SMSushmita Mitra
Sushmita Mitra
Rajiv RamanRajiv Raman
Rajiv Raman

27 December 2023
Verified
Book Chapter
Closed access
PDF file
SCSumit Chakraborty
Sumit Chakraborty
RBRiddhasree Bhattacharyya
Riddhasree Bhattacharyya
MCMaumita Chakraborty
Maumita Chakraborty
RPRajat Kumar Pal
Rajat Kumar Pal

21 April 2026
Verified
Book Chapter
Closed access
PDF file
RBRiddhasree Bhattacharyya
Riddhasree Bhattacharyya
SDShramana Dey
Shramana Dey
UCUnneta Chatterjee
Unneta Chatterjee
SMSushmita Mitra
Sushmita Mitra